Skip to main content
Elamipretide gains rare pediatric disease tag
3/4/2020

The FDA has granted rare pediatric disease designation to Stealth BioTherapeutics' candidate elamipretide as a treatment for Barth syndrome, a rare inherited condition.

Full Story: